The Human Psychopharmacology Research Unit is committed to the objective identification, measurement and comparison of the psychopharmacological effects of CNS-active products at all stages of their clinical development. HPRU excels in the analysis, interpretation and presentation of data to support medical marketing activities. Its integrated activities can speed up R&D processes.